Late Breaking Abstract - Open-label trial of budesonide/formoterol reliever therapy in mild asthma

J. Hardy (Wellington, New Zealand), C. Baggott (Wellington, New Zealand), J. Fingleton (Wellington, New Zealand), H. Reddel (Sydney, Australia), R. Hancox (Hamilton, New Zealand), M. Harwood (Auckland, New Zealand), A. Corin (Tauranga, New Zealand), J. Sparks (Wellington, New Zealand), D. Hall (Wellington, New Zealand), D. Sabbagh (Wellington, New Zealand), S. Mane (Wellington, New Zealand), S. Vohlidkova (Wellington, New Zealand), J. Martindale (Wellington, New Zealand), M. Williams (Wellington, New Zealand), P. Shirtcliffe (Wellington, New Zealand), M. Holliday (Wellington, New Zealand), M. Weatherall (Wellington, New Zealand), R. Beasley (Wellington, New Zealand)

Source: International Congress 2019 – Novel findings from asthma clinical trials
Session: Novel findings from asthma clinical trials
Session type: Oral Presentation
Number: 5332

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Hardy (Wellington, New Zealand), C. Baggott (Wellington, New Zealand), J. Fingleton (Wellington, New Zealand), H. Reddel (Sydney, Australia), R. Hancox (Hamilton, New Zealand), M. Harwood (Auckland, New Zealand), A. Corin (Tauranga, New Zealand), J. Sparks (Wellington, New Zealand), D. Hall (Wellington, New Zealand), D. Sabbagh (Wellington, New Zealand), S. Mane (Wellington, New Zealand), S. Vohlidkova (Wellington, New Zealand), J. Martindale (Wellington, New Zealand), M. Williams (Wellington, New Zealand), P. Shirtcliffe (Wellington, New Zealand), M. Holliday (Wellington, New Zealand), M. Weatherall (Wellington, New Zealand), R. Beasley (Wellington, New Zealand). Late Breaking Abstract - Open-label trial of budesonide/formoterol reliever therapy in mild asthma. 5332

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: